FDA Approved: RUKOBIA — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approves a supplemental application for RUKOBIA (fostemsavir tromethamine) from ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Rukobia (fostemsavir)

Snippet

SUPPL AP for RUKOBIA (FOSTEMSAVIR TROMETHAMINE)